Zobrazeno 1 - 10
of 184
pro vyhledávání: '"H. Lorberboum"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Immunology. 153:2497-2505
IL-2-PE40 is a chimeric protein composed of human IL-2 genetically fused to the amino terminus of a modified form of Pseudomonas exotoxin lacking its cell recognition domain. The immunosuppressive efficacy of IL-2-PE40 was demonstrated in several exp
Autor:
R W Kozak, H Lorberboum-Galski, L Jones, R K Puri, M C Willingham, T Malek, D J Fitzgerald, T A Waldmann, I Pastan
Publikováno v:
The Journal of Immunology. 145:2766-2771
A number of different immunotherapeutic reagents are currently being developed to target IL-2R for the treatment of leukemia, graft rejection, and certain autoimmune diseases. Previously, we have shown that IL-2-PE40, a chimeric protein composed of h
Autor:
Thomas A. Waldmann, Maurice K. Gately, Richard E. Clark, Desmond J. Fitzgerald, Vijay K. Chaudhary, H. Lorberboum-Galski, P. S. Brown, R. J. Garsia, Ira Pastan
Publikováno v:
Journal of Biological Chemistry. 265:16311-16317
To produce a molecule that will kill activated T cells as well as lymphomas and leukemias expressing interleukin 2 (IL2) receptors, we have created a recombinant chimeric protein in which IL2 is attached in peptide linkage to a truncated mutant form
Autor:
Y, Azar, H, Lorberboum-Galski
Publikováno v:
Apoptosis : an international journal on programmed cell death. 5(6)
In recent years chimeric proteins carrying bacterial toxins as their killing moiety, have been developed to selectively recognize and kill cell populations expressing speciific receptors. The involvement of Gonadotropin releasing hormone (GnRH) has b
Autor:
Robert Lafyatis, Ira Pastan, John Case, David J. FitzGerald, Ronald L. Wilder, H. Lorberboum-Galski
Publikováno v:
International journal of immunopharmacology. 13(2-3)
IL-2-PE40 is a chimeric cytotoxin composed of interleukin 2 (IL-2) fused to a truncated form of Pseudomonas exotoxin (PE) that lacks its binding domain. IL-2-PE40 has been shown to exhibit therapeutic potency in several models in vivo when administer
Autor:
H, Lorberboum-Galski, R J, Garsia, M, Gately, P S, Brown, R E, Clark, T A, Waldmann, V K, Chaudhary, D J, FitzGerald, I, Pastan
Publikováno v:
The Journal of biological chemistry. 265(27)
To produce a molecule that will kill activated T cells as well as lymphomas and leukemias expressing interleukin 2 (IL2) receptors, we have created a recombinant chimeric protein in which IL2 is attached in peptide linkage to a truncated mutant form
Autor:
S. Yarkoni, H. Lorberboum-Galski
Publikováno v:
JNCI Journal of the National Cancer Institute. 89:94-95
Autor:
GOMES GUIDOTI, DANIELA GRANELLA1 clmscrocha@yahoo.com.br, TEIXEIRA GUIDO, DAVID2, LOPES ROMERO, ADRIANO3, TASCA GOIS RUIZ, ANA LÚCIA4, FOGLIO, MARY ANN4, DE CARVALHO, JOÃO ERNESTO4, DE MELLO SARTORI CARDOSO DA ROCHA, CARMEM LÚCIA5
Publikováno v:
Journal of Neotropical Biology / Revista de Biologia Neotropical. jan-jul2024, Vol. 21 Issue 1, p17-28. 12p.